Abstract :
Stroke remains a leading cause of disability and death worldwide, with significant public health implications. Ischemic stroke is classified into various subtypes based on etiology, including large-artery atherosclerosis, small-vessel occlusion, and cardioembolism. The middle cerebral artery is often the most affected. The concept of the ischemic core and penumbra is crucial in understanding stroke pathology, where the core suffers irreversible damage, and the penumbra is at high risk if reperfusion is not timely. Genetic predispositions play a significant role in ischemic stroke, with heritability estimates around 37.9%. Monogenic causes account for 1-5% of cases, while polygenic factors are more prevalent. Genome-wide association studies (GWAS) have identified numerous genetic loci associated with ischemic stroke, revealing the complex genetic architecture of the disease. Molecular pathways such as neuroinflammation, excitotoxicity, oxidative stress, apoptosis, and autophagy are involved in the pathophysiology of ischemic stroke. Understanding these pathways offers potential therapeutic targets. This review aims to synthesise recent genetic studies and provide insights into future directions for research and clinical practice in ischemic stroke, emphasising the importance of personalised medicine and targeted therapies.
Keywords :
Genome-wide association studies (GWAS), Ischemic stroke, strokeReferences :
- Litak J, Mazurek M, Kulesza B, Szmygin P, Litak J, Kamieniak P, et al. Cerebral Small Vessel Disease. International Journal of Molecular Sciences. 2020 Dec 20;21(24):9729.
- Markus HS, de Leeuw FE. Cerebral small vessel disease: Recent advances and future directions. International Journal of Stroke. 2022 Dec 27;18(1):4–14.
- Giau VV, Bagyinszky E, Youn YC, An SSA, Kim SY. Genetic Factors of Cerebral Small Vessel Disease and Their Potential Clinical Outcome. International Journal of Molecular Sciences. 2019 Sep 3;20(17):4298.
- Marini S, Anderson CD, Rosand J. Genetics of Cerebral Small Vessel Disease. Journal of the American Heart Association. 2019 Jan 1;51(1):12-20.
- Chung J, Marini S, Pera J, Norrving B, Jordi Jimenez-Conde, Jaume Roquer, et al. Genome-wide association study of cerebral small vessel disease reveals established and novel loci. Brain. 2019 Oct 1;142(10):3176–89.
- Shi Y, Guo L, Chen Y, Xie Q, Yan Z, Liu Y et al. Risk factors for ischemic stroke: differences between cerebral small vessel and large artery atherosclerosis aetiologies. Folia Neuropathologica. 2021;59(4):378-385.
- Zhang K, Loong S, Yuen L, Narayanaswamy Venketasubramanian, Chin HL, Lai P, et al. Genetics in Ischemic Stroke: Current Perspectives and Future Directions. Journal of Cardiovascular Development and Disease. 2023 Dec 13;10(12):495–5.
- Navi BB, Kasner SE, Elkind MSV, Cushman M, Bang OY, DeAngelis LM. Cancer and Embolic Stroke of Undetermined Source.Journal of the American Heart Association. 2021 Jan 28;52(3):1121-1130.
- Ntaios G. Embolic Stroke of Undetermined Source: JACC Review Topic of the Week. J Am Coll 2020 Jan 28;75(3):333-340.
- Maida CD, Norrito RL, Daidone M, Tuttolomondo A, Pinto A. Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches. International Journal of Molecular Sciences. 2020 Sep 4; 21(18):6454.
- Pillai AA, Tadi P, Kanmanthareddy A. Cardioembolic Stroke [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jun 9]. Available from: https://pubmed.ncbi.nlm.nih.gov/30725675/
- Kamel H, Healey JS. Cardioembolic Stroke. Journal of the American Heart Association. 2017 Feb 3;120(3):514-526.
- Carinci M, Vezzani B, Patergnani S, et al. Different Roles of Mitochondria in Cell Death and Inflammation: Focusing on Mitochondrial Quality Control in Ischemic Stroke and Reperfusion. Biomedicines. 2021 Feb 9;9(2):169.
- An H, Zhou B, Ji X. Mitochondrial quality control in acute ischemic stroke. J Cereb Blood Flow Metab. 2021 Sep 22;41(12):3157-3170.
- Chakrabarty S, Govindaraj P, Sankaran BP, et al. Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. J Neurol. 2021 Jan 23;268(6):2192-2207.
- Ueda S, Yagi M, Tomoda E, et al. Mitochondrial haplotype mutation alleviates respiratory defect of MELAS by restoring taurine modification in tRNA with 3243A > G mutation. Nucleic Acids Res. 2023 Jul 13;51(14):7480-7495.
- Barros CDS, Coutinho A, Tengan CH. Arginine Supplementation in MELAS Syndrome: What Do We Know about the Mechanisms? International Journal of Molecular Sciences. 2024 Mar 24; 25(7):3629.
- Fan HC, Lee HF, Yue CT, Chi CS. Clinical Characteristics of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes. Life (Basel). 2021 Oct 20;11(11):1111.
- Ferro JM, Infante J. Cerebrovascular manifestations in hematological diseases: an update. J Neurol. 2021 Feb 13;268(9):3480-3492.
- Light J, Boucher M, Baskin-Miller J, Winstead M. Managing the Cerebrovascular Complications of Sickle Cell Disease: Current Perspectives. J Blood Med. 2023 Apr 14;14:279-293.
- Kim BK, Eah KY, Park JM. Essential Thrombocythemia and Ischemic Stroke: A Case Series of Five JAK2-Positive Patients. Medicina (Kaunas). 2023 Jul 14;59(7):1300.
- Balagopal K, Mathew A, Koshy AG, Jacob JP. Polycythemia Vera Presenting as Hemorrhagic Stroke. J Neurosci Rural Pract. 2021 May 5;12(3):601-602.
- Regimbeau M, Mary R, Hermetet F, Girodon F. Genetic Background of Polycythemia Vera. Genes (Basel). 2022 Apr 2;13(4):637.
- Cho BP, Harshfield EL, Al-Thani M, Tozer DJ, Bell S, Markus HS. Association of vascular risk factors and genetic factors with penetrance of variants causing monogenic stroke. JAMA neurology. 2022 Dec 1;79(12):1303-11.
- Chang LH, Chi NF, Chen CY, Lin YS, Hsu SL, Tsai JY, Huang HC, Lin CJ, Chung CP, Tung CY, Jeng CJ. Monogenic Causes in Familial Stroke Across Intracerebral Hemorrhage and Ischemic Stroke Subtypes Identified by Whole-Exome Sequencing. Cellular and Molecular Neurobiology. 2023 Aug;43(6):2769-83.
- Huang S, Joshi A, Shi Z, Wei J, Tran H, Zheng SL, Duggan D, Ashworth A, Billings L, Helfand BT, Qamar A. Combined polygenic scores for ischemic stroke risk factors aid risk assessment of ischemic stroke. International Journal of Cardiology. 2024 Jun 1;404:131990.
- Ekkert A, Šliachtenko A, Grigaitė J, Burnytė B, Utkus A, Jatužis D. Ischemic stroke genetics: what is new and how to apply it in clinical practice?. Genes. 2021 Dec 24;13(1):48.
- Li J, Abedi V, Zand R. Dissecting Polygenic Etiology of Ischemic Stroke in the Era of Precision Medicine. Journal of Clinical Medicine. 2022 Oct 11;11(20):5980.
- Liu X, Wang Q, Zhu R. Association of GWAS‐susceptibility loci with ischemic stroke recurrence in a Han Chinese population. The Journal of Gene Medicine. 2021 Jan;23(1):e3264.
- Lee JM, Fernandez-Cadenas I, Lindgren AG. Using human genetics to understand mechanisms in ischemic stroke outcome: from early brain injury to long-term recovery. Stroke. 2021 Sep;52(9):3013-24.
- Knol MJ, Lu D, Traylor M, Adams HH, Romero JR, Smith AV, Fornage M, Hofer E, Liu J, Hostettler IC, Luciano M. Association of common genetic variants with brain microbleeds: a genome-wide association study. Neurology. 2020 Dec 15;95(24):e3331-43.
- Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nature Reviews Cardiology. 2021 Sep;18(9):666-82.
- Kelly PJ, Lemmens R, Tsivgoulis G. Inflammation and stroke risk: a new target for prevention. Stroke. 2021 Aug;52(8):2697-706.
- Zhang T, Cao Y, Zhao J, Yao J, Liu G. Assessing the causal effect of genetically predicted metabolites and metabolic pathways on stroke. Journal of Translational Medicine. 2023 Nov 17;21(1):822.
- Debette S, Markus HS. Stroke genetics: discovery, insight into mechanisms, and clinical perspectives. Circulation Research. 2022 Apr 15;130(8):1095-111.
- Sukumaran R, Nair AS, Banerjee M. Ethnic and region-specific genetic risk variants of stroke and its comorbid conditions can define the variations in the burden of stroke and its phenotypic traits. eLife. 2024 Apr 2;13.
- Stefanou MI, Giannopapas V, Kitsos DK, Chondrogianni M, Theodorou A, Kosmidou M, Vlotinou P, Bakirtzis C, Andreadou E, Tzartos JS, Giannopoulos S. Prevalence and epidemiology of stroke in patients with multiple sclerosis: a systematic review and meta-analysis. Journal of Neurology. 2024 Apr 4:1-1.
- Rajashekar D, Wilms M, MacDonald ME, Schimert S, Hill MD, Demchuk A, Goyal M, Dukelow SP, Forkert ND. Lesion-symptom mapping with NIHSS sub-scores in ischemic stroke patients. Stroke and Vascular Neurology. 2022 Apr 1;7(2).
- Jung J, Lu Z, de Smith A, Mancuso N. Novel insight into the etiology of ischemic stroke gained by integrative multiome-wide association study. Human Molecular Genetics. 2024 Jan 15;33(2):170-81.
- Jung J, Lu Z, de Smith A, Mancuso N. Novel insight into the etiology of ischemic stroke gained by integrative transcriptome-wide association study. medRxiv. 2023 Mar 31.
- Wu BS, Chen SF, Huang SY, Ou YN, Deng YT, Chen SD, Dong Q, Yu JT. Identifying causal genes for stroke via integrating the proteome and transcriptome from brain and blood. Journal of translational medicine. 2022 Apr 21;20(1):181.
- Ekkert A, Šliachtenko A, Grigaitė J, Burnytė B, Utkus A, Jatužis D. Ischemic stroke genetics: what is new and how to apply it in clinical practice?. Genes. 2021 Dec 24;13(1):48.
- Debette S, Paré G. Stroke Genetics, Genomics, and Precision Medicine. Stroke. 2024 Mar 21.
- Cullell N, González-Sánchez J, Fernández-Cadenas I, Krupinski J. Generation and Applicability of Genetic Risk Scores (GRS) in Stroke. Stroke Biomarkers. 2020:23-34.
- Montaner J, Ramiro L, Simats A, Tiedt S, Makris K, Jickling GC, Debette S, Sanchez JC, Bustamante A. Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke. Nature Reviews Neurology. 2020 May;16(5):247-64.
- Chavda V, Chaurasia B, Garg K, Deora H, Umana GE, Palmisciano P, Scalia G, Lu B. Molecular mechanisms of oxidative stress in stroke and cancer. Brain Disorders. 2022 Mar 1;5:100029.
- Qin C, Yang S, Chu YH, Zhang H, Pang XW, Chen L, Zhou LQ, Chen M, Tian DS, Wang W. Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions. Signal transduction and targeted therapy. 2022 Jul 6;7(1):215.
- Mao R, Zong N, Hu Y, Chen Y, Xu Y. Neuronal death mechanisms and therapeutic strategy in ischemic stroke. Neuroscience bulletin. 2022 Oct;38(10):1229-47.
- Tuo QZ, Zhang ST, Lei P. Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications. Medicinal research reviews. 2022 Jan;42(1):259-305.
- Klegeris A. Regulation of neuroimmune processes by damage-and resolution-associated molecular patterns. Neural Regeneration Research. 2021 Mar 1;16(3):423-9.
- Chavda V, Chaurasia B, Garg K, Deora H, Umana GE, Palmisciano P, Scalia G, Lu B. Molecular mechanisms of oxidative stress in stroke and cancer. Brain Disorders. 2022 Mar 1;5:100029.
- Fang C, Xu H, Yuan L, Zhu Z, Wang X, Liu Y, Zhang A, Shao A, Lou M. Natural compounds for SIRT1‐mediated oxidative stress and neuroinflammation in stroke: a potential therapeutic target in the future. Oxidative medicine and cellular longevity. 2022;2022(1):1949718.
- Liu Y, Fang Y, Zhang Z, Luo Y, Zhang A, Lenahan C, Chen S. Ferroptosis: An emerging therapeutic target in stroke. Journal of neurochemistry. 2022 Jan;160(1):64-73.
- Debette S, Markus HS. Stroke Genetics: Discovery, Insight Into Mechanisms, and Clinical Perspectives. Circulation Research. 2022 Apr 15;130(8):1095–111.
- Granata A. Functional genomics in stroke: current and future applications of iPSCs and gene editing to dissect the function of risk variants. 2023 Apr 29;23(1).